Graves Light Lenhart Wealth’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $268K | Sell |
11,133
-33
| -0.3% | -$863 | 0.03% | 172 |
|
|
2026
Q1 | $314K | Sell |
11,166
-158
| -1% | -$4.21K | 0.03% | 148 |
|
|
2025
Q4 | $282K | Buy |
11,324
+282
| +3% | +$7.11K | 0.03% | 156 |
|
|
2025
Q3 | $281K | Sell |
11,042
-219
| -2% | -$5.41K | 0.03% | 152 |
|
|
2025
Q2 | $273K | Sell |
11,261
-312
| -3% | -$7.28K | 0.03% | 154 |
|
|
2025
Q1 | $293K | Buy |
11,573
+30
| +0.3% | +$785 | 0.04% | 145 |
|
|
2024
Q4 | $306K | Buy |
11,543
+29
| +0.3% | +$787 | 0.04% | 147 |
|
|
2024
Q3 | $333K | Sell |
11,514
-262
| -2% | -$7.64K | 0.04% | 138 |
|
|
2024
Q2 | $332K | Sell |
11,776
-830
| -7% | -$22.9K | 0.04% | 138 |
|
|
2024
Q1 | $350K | Sell |
12,606
-5,135
| -29% | -$142K | 0.04% | 135 |
|
|
2023
Q4 | $511K | Sell |
17,741
-1,013
| -5% | -$30.6K | 0.06% | 108 |
|
|
2023
Q3 | $621K | Sell |
18,754
-1,109
| -6% | -$39.2K | 0.08% | 96 |
|
|
2023
Q2 | $729K | Buy |
19,863
+281
| +1% | +$10.9K | 0.1% | 98 |
|
|
2023
Q1 | $799K | Sell |
19,582
-472
| -2% | -$20.4K | 0.12% | 83 |
|
|
2022
Q4 | $1.03M | Sell |
20,054
-1,579
| -7% | -$75.7K | 0.16% | 82 |
|
|
2022
Q3 | $947K | Sell |
21,633
-974
| -4% | -$47.3K | 0.16% | 81 |
|
|
2022
Q2 | $1.19M | Sell |
22,607
-134
| -0.6% | -$6.83K | 0.18% | 76 |
|
|
2022
Q1 | $1.18M | Buy |
22,741
+3,971
| +21% | +$206K | 0.16% | 76 |
|
|
2021
Q4 | $1.11M | Buy |
18,770
+19
| +0.1% | +$941 | 0.16% | 79 |
|
|
2021
Q3 | $806K | Buy |
18,751
+21
| +0.1% | +$930 | 0.13% | 82 |
|
|
2021
Q2 | $733K | Buy |
18,730
+24
| +0.1% | +$933 | 0.12% | 81 |
|
|
2021
Q1 | $678K | Buy |
18,706
+1,426
| +8% | +$50.6K | 0.12% | 83 |
|
|
2020
Q4 | $636K | Sell |
17,280
-2,380
| -12% | -$87.3K | 0.12% | 85 |
|
|
2020
Q3 | $685K | Sell |
19,660
-818
| -4% | -$28.7K | 0.15% | 76 |
|
|
2020
Q2 | $635K | Sell |
20,478
-2,596
| -11% | -$88.2K | 0.15% | 77 |
|
|
2020
Q1 | $715K | Sell |
23,074
-321
| -1% | -$10.9K | 0.19% | 71 |
|
|
2019
Q4 | $870K | Buy |
23,395
+259
| +1% | +$9.22K | 0.18% | 74 |
|
|
2019
Q3 | $842K | Sell |
23,136
-2,905
| -11% | -$106K | 0.19% | 76 |
|
|
2019
Q2 | $1.07M | Buy |
26,041
+1,380
| +6% | +$54.8K | 0.26% | 67 |
|
|
2019
Q1 | $994K | Sell |
24,661
-1,451
| -6% | -$58.1K | 0.25% | 65 |
|
|
2018
Q4 | $1.08M | Buy |
+26,112
| New | +$1.08M | 0.32% | 63 |
|
Other funds holding PFE
Graves Light Lenhart Wealth's PFE Position: Q2 2026 in Review
Graves Light Lenhart Wealth reduced its Pfizer (PFE) stake by 0.3% in Q2 2026, selling an estimated $863 and leaving 11,133 shares worth $268K. The position accounts for 0.03% of the portfolio, ranked #172.
Graves Light Lenhart Wealth first reported a position in PFE in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.19M in Q2 2022. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Graves Light Lenhart Wealth held 11,133 shares of Pfizer worth $268K as of Q2 2026.
- Graves Light Lenhart Wealth sold 33 Pfizer shares in Q2 2026, an estimated $863.
- Pfizer made up 0.03% of Graves Light Lenhart Wealth's portfolio in Q2 2026, its #172 holding.
- Graves Light Lenhart Wealth first reported a position in Pfizer in Q4 2018 and has held it in 31 quarters since.
- Graves Light Lenhart Wealth's Pfizer position peaked at $1.19M in Q2 2022.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Graves Light Lenhart Wealth's 13F filing for Q2 2026, filed 7 Jul 2026.